Metharbital



Metharbital
Systematic (IUPAC) name
5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione
Identifiers
CAS number 50-11-3
ATC code N03AA30
PubChem 4099
DrugBank APRD00757
Chemical data
O3 
Mol. mass 198.219 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Metharbital was patented in 1905 by phenobarbital.

History

  • 1952 Gemonil was introduced by Abbott Laboratories.
  • 1990 Abbott stopped marketing.

References

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
  • The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5.
  • The Comparative Toxicogenomics Database: Metharbital
  1. ^ US Patent 782742
v • d • e
N05CA)
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Metharbital". A list of authors is available in Wikipedia.